Equities

Heartseed Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
219A:TYO

Heartseed Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)1,971.00
  • Today's Change37.00 / 1.91%
  • Shares traded440.60k
  • 1 Year change+5.57%
  • Beta--
Data delayed at least 15 minutes, as of Feb 18 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Heartseed Inc is a Japan-based company engaged in research and development of regenerative medicine products. The Company has established cardiac regenerative medicine, a therapy in which microtissue (cardiomyocytes) derived from iPS cells are transplanted into the heart, and conducts business activities for patients with severe heart failure. Target diseases include dilated cardiomyopathy (DCM), old myocardial infarction (OMI), and dilated-phase hypertrophic cardiomyopathy (D-HCM). Except the pipeline's leading cardiac treatment HS-001 (administration of regenerated myocardium derived from allogeneic iPS cells to the myocardium), the Company also conducts research into the creation of myocardium using autologous iPS cells that do not pose immune rejection reactions and iPS cells with HLA knockout.

  • Revenue in JPY (TTM)--
  • Net income in JPY--
  • Incorporated2015
  • Employees39.00
  • Location
    Heartseed Inc5F, Seavans South Bldg., 1-2-3, ShibauraMINATO-KU 105-0023JapanJPN
  • Phone+81 363801068
  • Websitehttps://heartseed.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nano Holdings Inc156.34m-887.50m11.68bn20.00--4.50--79.57-12.46-12.462.1936.190.030844.495.297,817,050.00-17.51-23.68-22.01-25.3789.5482.69-567.67-746.835.93--0.4829---19.92-27.80-7.10------
Kidswell Bio Corp7.06bn23.83m12.85bn37.00242.857.16563.571.951.141.14150.1138.831.306.3823.34190,934,200.000.4375-16.750.678-27.0627.4547.460.3374-28.292.76--0.5768--109.0336.3798.51--27.20--
Pharma Foods International Co., Ltd.66.38bn-1.88bn18.99bn613.00--1.95--0.2769-64.99-64.992,293.41324.902.021.7015.01108,280,600.00-5.746.92-16.0118.9080.3280.70-2.843.340.6512-8.210.615133.245.0133.56-88.52-11.84-0.16124.08
AnGes Inc874.12m-5.23bn23.74bn55.00--7.71--27.61-15.21-15.212.467.910.17350.34878.45---103.74-49.52-189.41-59.1636.6531.53-597.83-3,839.321.18-23.870.0174--35.8185.3181.42---29.27--
Heartseed Inc-100.00bn-100.00bn45.49bn39.00--6.14----------314.76------------------------22.15--0.00004--------------
Healios KK104.00m-2.22bn51.57bn65.00--8.73--479.00-25.70-25.700.966142.250.0067--0.4952---14.27-23.01-18.09-30.33-109.62---2,143.27-2,221.73----0.5993---81.4330.9647.65---11.70--
Shin Nippon Biomedical Laboratories Ltd31.37bn3.99bn69.90bn1.44k17.491.329.802.2295.8495.84753.611,269.670.29831.015.5921,848,400.003.739.905.3114.8251.5952.6812.5023.350.6308--0.438330.4922.5517.36-10.9614.0754.7958.49
3-D Matrix Ltd8.47bn6.47m73.58bn114.00--17.6091.678.29-2.67-2.6771.6132.901.250.98494.6174,276,300.000.0958-35.520.1222-46.1268.6759.660.0764-55.662.53--0.2619--51.1159.47-878.94---7.64--
Takara Bio Inc44.15bn-7.20bn114.52bn1.78k--1.31--3.00-59.79-59.79366.64839.160.35351.485.4924,816,750.00-5.738.66-6.129.7053.9963.76-16.2017.163.83-4.820.089831.403.535.44-29.59-22.8820.4616.27
GNI Group Ltd26.84bn-4.41bn143.66bn867.00--2.90--5.42-80.69-80.69511.58900.920.34472.184.01---9.400.5414-11.370.647574.4980.97-27.261.283.79-2.990.0941--13.6722.39-501.65--34.24--
SanBio Co Ltd0.00-3.44bn176.04bn29.00--316.25-----48.26-48.260.006.830.00----0.00-138.65-47.32-177.12-57.01-----------12.420.725-------9.02---46.04--
Peptidream Inc18.52bn-3.75bn203.92bn621.00--3.52--9.84-28.99-28.99143.24398.780.21823.753.32---4.428.02-5.869.7240.6164.82-20.2418.771.53-16.770.24850.00-60.329.66-124.97--24.52--
Data as of Feb 18 2026. Currency figures normalised to Heartseed Inc's reporting currency: Japanese Yen JPY

Institutional shareholders

1.09%Per cent of shares held by top holders
HolderShares% Held
Rheos Capital Works, Inc. (Investment Management)as of 18 Nov 2024100.00k0.44%
Asset Management One Co., Ltd.as of 16 Sep 202590.90k0.40%
Amova Asset Management Co., Ltd.as of 29 Sep 202529.70k0.13%
Simplex Asset Management Co., Ltd.as of 05 Feb 202627.30k0.12%
Amundi Japan Ltd.as of 10 Sep 2025700.000.00%
More ▼
Data from 30 Sep 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.